Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: An incidental finding?(432 views) De Rosa A, Rinaldi C, Tucci T, Pappata S, Rossi F, Morra VB, Faggiano A, Colao A, De Michele G
Department of Neurological Sciences, Federico II University, Via Pansini 5, 80131 Naples, Italy
Biostructure and Bioimaging Institute, CNR, Department of Biomorphological and Functional Sciences, Federico II University, Naples, Italy
Department of Molecular and Clinical Endocrinology, Federico II University of Naples, Naples, Italy
References: Jay, C.A., Abrams, G.M., Other endocrinopathies of the nervous system (2008) Neurology and General Medicine, pp. 427-440. , Churchill Livingstone, New York, M.J. Aminoff (Ed.
Vaamonde, J., Legarda, I., Jimenez-Jimenez, J., Zubieta, J.L., Obeso, J.A., Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism (1993) Mov Disord, 8, pp. 398-400
Margolin, D., Hammerstad, J., Orwoll, E., McClung, M., Calhoun, D., Intracranial calcification in hyperparathyroidism associated with gait apraxia and parkinsonism (1980) Neurology, 30, pp. 1005-1007
Hirooka, Y., Yuasa, K., Hibi, K., Ishikawa, A., Sobue, G., Naruse, T., Hyperparathyroidism associated with parkinsonism (1992) Intern Med, 31, pp. 904-907
Kovacs, C.S., Howse, D.C., Yendt, E.R., Reversible parkinsonism induced by hypercalcemia and primary hyperparathyroidism (1993) Arch Intern Med, 153, pp. 1134-1136
Adami, S., Marcocci, C., Gatti, D., Epidemiology of primary hyperparathyroidism in Europe (2002) Bone Miner Res, 17 (SUPPL. 2), pp. N18-N23
Walker, M.D., McMahon, D.J., Inabnet, W.B., Lazar, R.M., Brown, I., Vardy, S., Neuropsychological features in primary hyperparathyroidism: a prospective study (2009) J Clin Endocrinol Metab, 94, pp. 1951-1958
Bofill-Cardona, E., Kudlacek, O., Yang, Q., Ahorn, H., Freissmuth, M., Nanoff, C., Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch (2000) J Biol Chem, 275, pp. 32672-32680
Mosharov, E.V., Larsen, K.E., Kanter, E., Phillips, K.A., Wilson, K., Schmitz, Y., Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons (2009) Neuron, 30, pp. 218-229
Jay, C. A., Abrams, G. M., Other endocrinopathies of the nervous system (2008) Neurology and General Medicine, pp. 427-440. , Churchill Livingstone, New York, M. J. Aminoff (Ed.
Kovacs, C. S., Howse, D. C., Yendt, E. R., Reversible parkinsonism induced by hypercalcemia and primary hyperparathyroidism (1993) Arch Intern Med, 153, pp. 1134-1136
Walker, M. D., McMahon, D. J., Inabnet, W. B., Lazar, R. M., Brown, I., Vardy, S., Neuropsychological features in primary hyperparathyroidism: a prospective study (2009) J Clin Endocrinol Metab, 94, pp. 1951-1958
Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons (2009) Neuron, 30, pp. 218-229
Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: An incidental finding?
Not available.
Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: An incidental finding?
No results.
Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: An incidental finding?
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(730 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote